Inventor · disambiguated record
Lars Wallentin
Also filed as: WALLENTIN LARS
3 granted patents·1 pending application·16 citations·filing 1999–2019
60Inventor score
Top patents by PatentIndex Score
4 records- 0161US11199552B2Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereofMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2019·Granted Dec 14, 2021·0 cites·8 claims
- 0246US8951742B2Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereofWOLLERT KAI C·Filed 2009·Granted Feb 10, 2015·0 cites·35 claims
- 0346US6258798B1Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparinPHARMACIA AB·Filed 1999·Granted Jul 10, 2001·16 cites·15 claims
- 0432US2015362511A1Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of gdf-15, natriuretic peptide, cardiac troponin or combinations thereofHANNOVER MED HOCHSCHULE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Wallentin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →